메뉴 건너뛰기




Volumn , Issue , 2009, Pages 553-568

Tissue levels of androgens in castration-recurrent prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84901087159     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-69179-4_23     Document Type: Chapter
Times cited : (6)

References (53)
  • 1
    • 0024996361 scopus 로고
    • Enzymes of androgen formation and degradation in the human prostate
    • Bartsch, W., Klein, H., Schiemann, U., Bauer, H. W., & Voigt, K. D. (1990). Enzymes of androgen formation and degradation in the human prostate. Ann N Y Acad Sci, 595, 53-66.
    • (1990) Ann N y Acad Sci , vol.595 , pp. 53-66
    • Bartsch, W.1    Klein, H.2    Schiemann, U.3    Bauer, H.W.4    Voigt, K.D.5
  • 2
    • 31444440675 scopus 로고    scopus 로고
    • Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha, 17beta-diol to 5alpha-dihydrotestosterone: A potential therapeutic target for androgen-dependent disease
    • Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., & Penning, T. M. (2006). Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha, 17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol Endocrinol, 20(2), 444-458.
    • (2006) Mol Endocrinol , vol.20 , Issue.2 , pp. 444-458
    • Bauman, D.R.1    Steckelbroeck, S.2    Williams, M.V.3    Peehl, D.M.4    Penning, T.M.5
  • 3
    • 0024318399 scopus 로고
    • Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men
    • Belanger, B., Belanger, A., Labrie, F., Dupont, A., Cusan, L., & Monfette, G. (1989). Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J Steroid Biochem, 32(5), 695-698.
    • (1989) J Steroid Biochem , vol.32 , Issue.5 , pp. 695-698
    • Belanger, B.1    Belanger, A.2    Labrie, F.3    Dupont, A.4    Cusan, L.5    Monfette, G.6
  • 4
    • 0036772932 scopus 로고    scopus 로고
    • Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer
    • Brown, R. S., Edwards, J., Dogan, A., Payne, H., Harland, S. J., Bartlett, J. M., et al. (2002). Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J Pathol, 198(2), 237-244.
    • (2002) J Pathol , vol.198 , Issue.2 , pp. 237-244
    • Brown, R.S.1    Edwards, J.2    Dogan, A.3    Payne, H.4    Harland, S.J.5    Bartlett, J.M.6
  • 5
    • 0025849053 scopus 로고
    • Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
    • Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., et al. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324(17), 1156-1161.
    • (1991) N Engl J Med , vol.324 , Issue.17 , pp. 1156-1161
    • Catalona, W.J.1    Smith, D.S.2    Ratliff, T.L.3    Dodds, K.M.4    Coplen, D.E.5    Yuan, J.J.6
  • 6
    • 0032883932 scopus 로고    scopus 로고
    • Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
    • Culig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., et al. (1999). Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer, 81(2), 242-251.
    • (1999) Br J Cancer , vol.81 , Issue.2 , pp. 242-251
    • Culig, Z.1    Hoffmann, J.2    Erdel, M.3    Eder, I.E.4    Hobisch, A.5    Hittmair, A.6
  • 7
    • 0031038011 scopus 로고    scopus 로고
    • Human androgen receptor expression in prostate cancer following androgen ablation
    • de Vere White, R., Meyers, F., Chi, S. G., Chamberlain, S., Siders, D., Lee, F., et al. (1997). Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol, 31(1), 1-6.
    • (1997) Eur Urol , vol.31 , Issue.1 , pp. 1-6
    • De Vere White, R.1    Meyers, F.2    Chi, S.G.3    Chamberlain, S.4    Siders, D.5    Lee, F.6
  • 8
    • 0042978480 scopus 로고    scopus 로고
    • Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
    • Edwards, J., Krishna, N. S., Grigor, K. M., & Bartlett, J. M. (2003). Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer, 89(3), 552-556.
    • (2003) Br J Cancer , vol.89 , Issue.3 , pp. 552-556
    • Edwards, J.1    Krishna, N.S.2    Grigor, K.M.3    Bartlett, J.M.4
  • 10
    • 0035496220 scopus 로고    scopus 로고
    • The development of androgen-independent prostate cancer
    • Feldman, B. J., & Feldman, D. (2001). The development of androgen-independent prostate cancer. Nat Rev Cancer, 1(1), 34-45.
    • (2001) Nat Rev Cancer , vol.1 , Issue.1 , pp. 34-45
    • Feldman, B.J.1    Feldman, D.2
  • 11
    • 0141954183 scopus 로고    scopus 로고
    • Androgen receptor gene amplification and protein expression in recurrent prostate cancer
    • Ford, O. H., 3rd, Gregory, C. W., Kim, D., Smitherman, A. B., & Mohler, J. L. (2003). Androgen receptor gene amplification and protein expression in recurrent prostate cancer. J Urol, 170(5), 1817-1821.
    • (2003) J Urol , vol.170 , Issue.5 , pp. 1817-1821
    • Ford, O.H.1    Gregory III, C.W.2    Kim, D.3    Smitherman, A.B.4    Mohler, J.L.5
  • 12
    • 2342614947 scopus 로고    scopus 로고
    • Cholesterol and prostate cancer
    • Freeman M. R., & Solomon, K. R. (2004). Cholesterol and prostate cancer. J Cell Biochem 91(1) 54-69.
    • (2004) J Cell Biochem , vol.91 , Issue.1 , pp. 54-69
    • Freeman, M.R.1    Solomon, K.R.2
  • 14
    • 0018649003 scopus 로고
    • Steroid levels in cancer of the prostate-markers of tumour differentiation and adequacy of anti-androgen therapy
    • Geller, J., Albert, J., & Loza, D. (1979). Steroid levels in cancer of the prostate-markers of tumour differentiation and adequacy of anti-androgen therapy. J Steroid Biochem, 11(1B), 631-636.
    • (1979) J Steroid Biochem , vol.11 , Issue.1 B , pp. 631-636
    • Geller, J.1    Albert, J.2    Loza, D.3
  • 15
    • 0036645414 scopus 로고    scopus 로고
    • Molecular biology of the androgen receptor
    • Gelmann, E. P. (2002). Molecular biology of the androgen receptor. J Clin Oncol, 20(13), 3001-3015.
    • (2002) J Clin Oncol , vol.20 , Issue.13 , pp. 3001-3015
    • Gelmann, E.P.1
  • 16
    • 0032535307 scopus 로고    scopus 로고
    • Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
    • Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., et al. (1998). Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res, 58(24), 5718-5724.
    • (1998) Cancer Res , vol.58 , Issue.24 , pp. 5718-5724
    • Gregory, C.W.1    Hamil, K.G.2    Kim, D.3    Hall, S.H.4    Pretlow, T.G.5    Mohler, J.L.6
  • 17
    • 0033306866 scopus 로고    scopus 로고
    • Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft
    • Gregory, C. W., Kim, D., Ye, P., D'Ercole, A. J., Pretlow, T. G., Mohler, J. L., et al. (1999). Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology, 140(5), 2372-2381.
    • (1999) Endocrinology , vol.140 , Issue.5 , pp. 2372-2381
    • Gregory, C.W.1    Kim, D.2    Ye, P.3    D'Ercole, A.J.4    Pretlow, T.G.5    Mohler, J.L.6
  • 18
    • 0035361340 scopus 로고    scopus 로고
    • A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy
    • Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., et al. (2001a). A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res, 61(11), 4315-4319.
    • (2001) Cancer Res , vol.61 , Issue.11 , pp. 4315-4319
    • Gregory, C.W.1    He, B.2    Johnson, R.T.3    Ford, O.H.4    Mohler, J.L.5    French, F.S.6
  • 19
    • 0035300409 scopus 로고    scopus 로고
    • Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen
    • Gregory, C. W., Johnson, R. T., Jr., Mohler, J. L., French, F. S., & Wilson, E. M. (2001b). Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res, 61(7), 2892-2898.
    • (2001) Cancer Res , vol.61 , Issue.7 , pp. 2892-2898
    • Gregory, C.W.1    Johnson Jr., R.T.2    Mohler, J.L.3    French, F.S.4    Wilson, E.M.5
  • 20
    • 0034935259 scopus 로고    scopus 로고
    • Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft
    • Gregory, C. W., Johnson, R. T., Jr., Presnell, S. C., Mohler, J. L., & French, F. S. (2001c). Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft. J Androl, 22(4), 537-548.
    • (2001) J Androl , vol.22 , Issue.4 , pp. 537-548
    • Gregory, C.W.1    Johnson Jr., R.T.2    Presnell, S.C.3    Mohler, J.L.4    French, F.S.5
  • 21
    • 0035930133 scopus 로고    scopus 로고
    • Androgen receptor signaling in androgen-refractory prostate cancer
    • Grossmann, M. E., Huang, H., & Tindall, D. J. (2001). Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst, 93(22), 1687-1697.
    • (2001) J Natl Cancer Inst , vol.93 , Issue.22 , pp. 1687-1697
    • Grossmann, M.E.1    Huang, H.2    Tindall, D.J.3
  • 22
    • 33749445413 scopus 로고    scopus 로고
    • Regulation of androgen receptor activity by tyrosine phosphorylation
    • Guo, Z., Dai, B., Jiang, T., Xu, K., Xie, Y., Kim, O., et al. (2006). Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell, 10(4), 309-319.
    • (2006) Cancer Cell , vol.10 , Issue.4 , pp. 309-319
    • Guo, Z.1    Dai, B.2    Jiang, T.3    Xu, K.4    Xie, Y.5    Kim, O.6
  • 23
    • 0015970931 scopus 로고
    • Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro
    • Harper, M. E., Pike, A., Peeling, W. B., & Griffiths, K. (1974). Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro. J Endocrinol, 60(1), 117-125.
    • (1974) J Endocrinol , vol.60 , Issue.1 , pp. 117-125
    • Harper, M.E.1    Pike, A.2    Peeling, W.B.3    Griffiths, K.4
  • 24
    • 0029072101 scopus 로고
    • Distant metastases from prostatic carcinoma express androgen receptor protein
    • Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H., & Hittmair, A. (1995). Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res, 55(14), 3068-3072.
    • (1995) Cancer Res , vol.55 , Issue.14 , pp. 3068-3072
    • Hobisch, A.1    Culig, Z.2    Radmayr, C.3    Bartsch, G.4    Klocker, H.5    Hittmair, A.6
  • 25
    • 0036680098 scopus 로고    scopus 로고
    • Hormones and prostate cancer: Current perspectives and future directions
    • Hsing, A. W., Reichardt, J. K., & Stanczyk, F. Z. (2002). Hormones and prostate cancer: current perspectives and future directions. Prostate, 52(3), 213-235.
    • (2002) Prostate , vol.52 , Issue.3 , pp. 213-235
    • Hsing, A.W.1    Reichardt, J.K.2    Stanczyk, F.Z.3
  • 26
    • 0036636871 scopus 로고    scopus 로고
    • Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941
    • Huggins, C., & Hodges, C. V. (2002). Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol, 168(1), 9-12.
    • (2002) J Urol , vol.168 , Issue.1 , pp. 9-12
    • Huggins, C.1    Hodges, C.V.2
  • 28
    • 0020354138 scopus 로고
    • New hormonal therapy in prostatic carcinoma: Combined treatment with an LHRH agonist and an antiandrogen
    • Labrie, F., Dupont, A., Belanger, A., Cusan, L., Lacourciere, Y., Monfette, G., et al. (1982). New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. Clin Invest Med, 5(4), 267-275.
    • (1982) Clin Invest Med , vol.5 , Issue.4 , pp. 267-275
    • Labrie, F.1    Dupont, A.2    Belanger, A.3    Cusan, L.4    Lacourciere, Y.5    Monfette, G.6
  • 29
    • 0035328474 scopus 로고    scopus 로고
    • Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer
    • Linja, M. J., Savinainen, K. J., Saramaki, O. R., Tammela, T. L., Vessella, R. L., & Visakorpi, T. (2001). Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res, 61(9), 3550-3555.
    • (2001) Cancer Res , vol.61 , Issue.9 , pp. 3550-3555
    • Linja, M.J.1    Savinainen, K.J.2    Saramaki, O.R.3    Tammela, T.L.4    Vessella, R.L.5    Visakorpi, T.6
  • 30
    • 34347263425 scopus 로고    scopus 로고
    • Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation
    • Mahajan, N. P., Liu, Y., Majumder, S., Warren, M. R., Parker, C. E., Mohler, J. L., et al. (2007). Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA, 104(20), 8438-8443.
    • (2007) Proc Natl Acad Sci USA , vol.104 , Issue.20 , pp. 8438-8443
    • Mahajan, N.P.1    Liu, Y.2    Majumder, S.3    Warren, M.R.4    Parker, C.E.5    Mohler, J.L.6
  • 31
    • 0029103141 scopus 로고
    • Maximum androgen blockade in advanced prostate cancer: An overview of 22 randomised trials with 3283 deaths in 5710 patients
    • Prostate Cancer Trialists' Collaborative Group
    • Prostate Cancer Trialists' Collaborative Group (1995). Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. Lancet, 346(8970), 265-269.
    • (1995) Lancet , vol.346 , Issue.8970 , pp. 265-269
  • 32
    • 0034213320 scopus 로고    scopus 로고
    • Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
    • Miyake, H., Pollak, M., & Gleave, M. E. (2000). Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res, 60(11), 3058-3064.
    • (2000) Cancer Res , vol.60 , Issue.11 , pp. 3058-3064
    • Miyake, H.1    Pollak, M.2    Gleave, M.E.3
  • 33
    • 1642475101 scopus 로고    scopus 로고
    • The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor
    • Mizokami, A., Koh, E., Fujita, H., Maeda, Y., Egawa, M., Koshida, K., et al. (2004). The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Cancer Res, 64(2), 765-771.
    • (2004) Cancer Res , vol.64 , Issue.2 , pp. 765-771
    • Mizokami, A.1    Koh, E.2    Fujita, H.3    Maeda, Y.4    Egawa, M.5    Koshida, K.6
  • 34
    • 0036604401 scopus 로고    scopus 로고
    • Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer
    • Mohler, J. L., Morris, T. L., Ford, O. H., 3rd, Alvey, R. F., Sakamoto, C., & Gregory, C. W. (2002). Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate, 51(4), 247-255.
    • (2002) Prostate , vol.51 , Issue.4 , pp. 247-255
    • Mohler, J.L.1    Morris, T.L.2    Ford, O.H.3    Alvey III, R.F.4    Sakamoto, C.5    Gregory, C.W.6
  • 37
    • 0035845850 scopus 로고    scopus 로고
    • Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling
    • Mousses, S., Wagner, U., Chen, Y., Kim, J. W., Bubendorf, L., Bittner, M., et al. (2001). Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene, 20(46), 6718-6723.
    • (2001) Oncogene , vol.20 , Issue.46 , pp. 6718-6723
    • Mousses, S.1    Wagner, U.2    Chen, Y.3    Kim, J.W.4    Bubendorf, L.5    Bittner, M.6
  • 38
    • 8444231965 scopus 로고    scopus 로고
    • The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer
    • Nishiyama, T., Hashimoto, Y., & Takahashi, K. (2004). The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Clin Cancer Res, 10(21), 7121-7126.
    • (2004) Clin Cancer Res , vol.10 , Issue.21 , pp. 7121-7126
    • Nishiyama, T.1    Hashimoto, Y.2    Takahashi, K.3
  • 40
    • 33644881888 scopus 로고    scopus 로고
    • Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors
    • Penning, T. M., Steckelbroeck, S., Bauman, D. R., Miller, M. W., Jin, Y., Peehl, D. M., et al. (2006). Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol, 248(1-2), 182-191.
    • (2006) Mol Cell Endocrinol , vol.248 , Issue.1-2 , pp. 182-191
    • Penning, T.M.1    Steckelbroeck, S.2    Bauman, D.R.3    Miller, M.W.4    Jin, Y.5    Peehl, D.M.6
  • 41
    • 0033385487 scopus 로고    scopus 로고
    • Prostate cancer: Molecular biology of early progression to androgen independence
    • Sadar, M. D., Hussain, M., & Bruchovsky, N. (1999). Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer, 6(4), 487-502.
    • (1999) Endocr Relat Cancer , vol.6 , Issue.4 , pp. 487-502
    • Sadar, M.D.1    Hussain, M.2    Bruchovsky, N.3
  • 42
    • 0019761279 scopus 로고
    • Prostatic cholesterol metabolism: Regulation and alteration
    • Schaffner, C. P. (1981). Prostatic cholesterol metabolism: regulation and alteration. Prog Clin Biol Res, 75A, 279-324.
    • (1981) Prog Clin Biol Res , vol.75 A , pp. 279-324
    • Schaffner, C.P.1
  • 43
    • 0022639044 scopus 로고
    • Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
    • Simard, J., Luthy, I., Guay, J., Belanger, A., & Labrie, F. (1986). Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol, 44(3), 261-270.
    • (1986) Mol Cell Endocrinol , vol.44 , Issue.3 , pp. 261-270
    • Simard, J.1    Luthy, I.2    Guay, J.3    Belanger, A.4    Labrie, F.5
  • 44
    • 33645056171 scopus 로고    scopus 로고
    • Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
    • Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., et al. (2006). Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res, 66(5), 2815-2825.
    • (2006) Cancer Res , vol.66 , Issue.5 , pp. 2815-2825
    • Stanbrough, M.1    Bubley, G.J.2    Ross, K.3    Golub, T.R.4    Rubin, M.A.5    Penning, T.M.6
  • 45
    • 0026765022 scopus 로고
    • Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytologi-cal grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma
    • Stege, R., Tribukait, B., Lundh, B., Carlstrom, K., Pousette, A., & Hasenson, M. (1992). Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytologi-cal grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma. J Urol, 148(3), 833-837.
    • (1992) J Urol , vol.148 , Issue.3 , pp. 833-837
    • Stege, R.1    Tribukait, B.2    Lundh, B.3    Carlstrom, K.4    Pousette, A.5    Hasenson, M.6
  • 46
    • 0035176826 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: Evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts
    • Stewart, R. J., Panigrahy, D., Flynn, E., & Folkman, J. (2001). Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol, 165(2), 688-693.
    • (2001) J Urol , vol.165 , Issue.2 , pp. 688-693
    • Stewart, R.J.1    Panigrahy, D.2    Flynn, E.3    Folkman, J.4
  • 47
    • 0029011116 scopus 로고
    • Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
    • Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., et al. (1995). Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med, 332(21), 1393-1398.
    • (1995) N Engl J Med , vol.332 , Issue.21 , pp. 1393-1398
    • Taplin, M.E.1    Bubley, G.J.2    Shuster, T.D.3    Frantz, M.E.4    Spooner, A.E.5    Ogata, G.K.6
  • 48
    • 0033152164 scopus 로고    scopus 로고
    • Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
    • Taplin, M. E., Bubley, G. J., Ko, Y. J., Small, E. J., Upton, M., Rajeshkumar, B., et al. (1999). Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res, 59(11), 2511-2515.
    • (1999) Cancer Res , vol.59 , Issue.11 , pp. 2511-2515
    • Taplin, M.E.1    Bubley, G.J.2    Ko, Y.J.3    Small, E.J.4    Upton, M.5    Rajeshkumar, B.6
  • 50
    • 27644452640 scopus 로고    scopus 로고
    • Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
    • Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005b). Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res, 11(13), 4653-4657.
    • (2005) Clin Cancer Res , vol.11 , Issue.13 , pp. 4653-4657
    • Titus, M.A.1    Schell, M.J.2    Lih, F.B.3    Tomer, K.B.4    Mohler, J.L.5
  • 52
    • 0028944138 scopus 로고
    • In vivo amplification of the androgen receptor gene and progression of human prostate cancer
    • Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., et al. (1995). In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet, 9(4), 401-406.
    • (1995) Nat Genet , vol.9 , Issue.4 , pp. 401-406
    • Visakorpi, T.1    Hyytinen, E.2    Koivisto, P.3    Tanner, M.4    Keinanen, R.5    Palmberg, C.6
  • 53
    • 0026463927 scopus 로고
    • The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate
    • Yang, Y., Chisholm, G. D., & Habib, F. K. (1992). The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate. Prostate, 21(3), 201-208.
    • (1992) Prostate , vol.21 , Issue.3 , pp. 201-208
    • Yang, Y.1    Chisholm, G.D.2    Habib, F.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.